Bleomycin is an antitumor agent whose activity has long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacilus subtilis tRNAHis precursor in a highly selective fashion, but Escherichia coli tRNATYr precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, %10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single-and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity ofmechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.
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The bleomycins (BLMs) are antitumor antibiotics believed to function by DNA degradation (1, 2). DNA degradation is sequence-selective, occurring primarily at a subset of all 5'-GT-3' and 5'-GC-3' sequences (3, 4) . A wealth of information exists concerning the mechanism of BLM-mediated DNA degradation in cell-free (1, 2, 5) and cellular (5, 6) systems.
In contrast, few studies have dealt with RNA as a substrate for BLM. Further, in spite of the compartmentalization of DNA and RNA in nucleated cells, most studies of RNA cleavage have been carried out with DNA present. For example, BLM degraded only the poly(dT) strand of a poly(rA)-poly(dT) hybrid (7, 8) . Hori (9) showed that relaxation of simian virus 40 form I DNA was hardly affected by even a large excess of Escherichia coli tRNA. Those experiments that employed RNA alone were carried out in the absence of added metal ions (10, 11) . Magliozzo et al. (12) have reported degradation of yeast tRNAPhe by high concentrations of Fe(II)-BLM; product bands corresponding to <5-10% of the starting tRNA were observed by methylene blue staining of a polyacrylamide gel. Thin layer chromatographic analysis indicated products that comigrated with adenine and uracil.
Although none ofthe foregoing studies suggested that RNA might constitute an efficient substrate for BLM, ongoing studies in this laboratory of BLM-mediated DNA oligonucleotide degradation have demonstrated that alteration of DNA conformation can significantly change the pattern and extent of cleavage normally obtained with B-form DNA (13, 14) . On the chance that the limited RNA cleavage observed (vide supra) might actually have resulted from highly efficient cleavage at a few conformationally unique sites, we studied several RNAs as substrates. Presently, we show that Fe(II)-BLM does mediate RNA degradation and that the process is highly site-selective. tTo whom reprint requests should be addressed.
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PAGE. Reaction mixtures (5 /l) contained 12 pmol (-2 x 104 cpm) of 5'-32P-end-labeled tRNAHIS precursor, and 3 mM unfractionated E. coli tRNA or 3-5 pmol (-2 x 104 cpm) of 5'-32P-end-labeled DNA restriction fragment, and 3 mM sonicated calf thymus DNA, 5 mM NaH2PO4 (pH 7.0), and 3, 30, or 300 ,gM Fe(II)-BLM A2. The reactions were initiated by the addition of Fe(II) (at 0, 20, and 40 min) to a final concentration equimolar with BLM A2. The reactions were incubated at 220C for 1 hr and then analyzed by PAGE (20% gels, 2200 V, 6 hr).
The experiment shown in Fig. 4 was carried out using a 231-nucleotide RNA transcript. Reaction mixtures (5 ul) contained 18 pmol (-=4 x 104 cpm) of the radiolabeled RNA, 5 mM NaH2PO4 (pH 7.0), and 25 ,uM Fe(II)-BLM A2. The reaction was initiated by simultaneous addition of freshly prepared solutions of BLM A2 and Fe(II). After 10 min at 22°C, the reactions were quenched and analyzed by PAGE (20% gel).
Degradation of Synthetic Octanucleotides. Reaction mixtures (50,ul) contained oligonucleotide (1.0 mM, final concentration), 50 mM sodium cacodylate (pH 7.2), and 0.2 mM Fe(II)-BLM A2. The reactions were incubated at 0°C for 1 hr and then analyzed by C18 reverse-phase HPLC (17) .
RESULTS AND DISCUSSION
Site-Selective Cleavage of a tRNA Precursor. As shown in precursor was also observed in a reaction mixture that contained both tRNAHiS and tRNATYr precursors. Relative to BLM-mediated DNA degradation (1-4), RNA cleavage occurred at comparable drug concentrations but with much greater selectivity. The results suggest that BLM-mediated degradation is generally more efficient for DNA than for RNA but that some RNA sites undergo highly efficient strand scission that is little affected by nonsubstrate RNAs. Accordingly, it seems logical to anticipate that little RNA cleavage would occur in the presence of a large excess of DNA but that populations of RNA molecules relatively isolated from DNA (e.g., in the cytoplasm of nucleated cells) might undergo selective cleavage.
Characterization of FeBLM Cleavage Sites in RNAs. The position of tRNAHiS precursor cleavage by Fe-BLM was established by RNA sequence analysis (18) . As shown (Fig.  3) , the predominant site of cleavage was found to be uridine-35, located adjacent to guanosine in a single-stranded region at the base of the "acceptor stem." Whereas cleavage at this 5'-GU-3' is formally analogous to the cleavage of DNA at 5'-GC-3' and 5'-GT-3' sequences, the preference for cleavage within a single-stranded region is unprecedented (see, however ref. 19 ). Further, six other 5'-GU-3' sequences in the tRNA precursor were cleaved weakly or not at all; the minor sites actually observed (Fig. 3 ) included all four bases and reflected no obvious sequence selectivity. Also instructive is a comparison of the secondary structure of B. subtilis tRNAH's precursor with that of E. coli tRNATYr precursor. Although the tRNATYr precursor was not a good substrate for cleavage by Fe(II)-BLM, this tRNA precursor contains a 5'-GU-3' sequence analogous to the one cleaved in tRNAHiS precursor (Fig. 3) . Clearly, the dramatic difference in susceptibilities of these two tRNA precursors to degradation by Fe(II)-BLM argues for selective recognition of the tRNAHiS precursor at the level of tertiary structure; in fact, an alternate conformation for tRNATYr precursor has been suggested (20) . This would parallel the alteration of DNA sequence selectivity as DNA conformation was altered (13, 14, 21) .
Several other RNA transcripts were tested as potential substrates. Among these was a 5'-32P-end-labeled 231-nucleotide RNA transcript produced from pSP64 plasmid DNA. As shown in Fig. 4 , treatment with 25 ,tM Fe(II)'BLM A2 afforded cleavage at two major sites. One ofthese was also at the uridine-(-93) in a 5'-GU-3' sequence; although RNA folding analyses (22) cannot be considered definitive, the extensive complementarity involved in the present case suggests that this site can be represented reasonably as the last nucleotide within the double-stranded region of a stemloop structure (Fig. 4) . This structure is not unlike the major cleavage site in the tRNAHiS precursor. The second cleavage occurred at guanosine-122, which is part of a 5'-CG-3' sequence in which the cytidine is in a single-stranded region and the guanosine is the first of several nucleotides in a double-stranded region. Cleavage of this RNA occurred at Fe(II)-BLM to RNA nucleotide ratios comparable to those required for degradation of tRNAHiS precursor.
Susceptibility of Viral RNA to Fe-BLM. The present results challenge the assumption that DNA is the biochemical locus at which BLM mediates its therapeutic effects; it seemed logical to study the possible involvement of RNA by the use of an organism in which the genetic material consists ofRNA. Accordingly, we have studied the effect of Fe(II)-BLM on the mRNA that encodes HIV-1 reverse transcriptase. A 270-nucleotide 5'-32P-end-labeled RNA encoding the N terminus of HIV reverse transcriptase was obtained by transcription from a (Sca I linearized) pGEM plasmid. Treatment with Fe(II)-BLM at a BLM to RNA nucleotide ratio similar to that used for tRNA His precursor effected cleavage at four sites, CCU-AACATA. subset of all 5'-GC-3' and 5'-GT-3' sites, although it has become increasingly clear that BLM is also responsive to DNA conformational alterations (13, 14, 19, 21, 23) . Recognition of B-form DNA by Fe(II)-BLM primarily involves recognition of two adjacent bases and is optimal for 2 of the 10 possible distinguishable duplex sequences for a 2-base binding site (24) . For RNA, the present data do not indicate a preferred 2-base recognition sequence, although the cleavage of 5'-GU-3' sequences having appropriate conformations is clearly favorable, and many RNA nicks occur at or in proximity to guanosine residues. It seems unlikely that recognition of RNA by Fe(II)-BLM involves a recognition sequence of different length than for DNA. For RNA, the characterized lesions all reflect damage at what can be represented as junctions between single-and double-stranded regions. Given the lack of any obvious recognition sequence for BLM in RNA and the extraordinary selectivity of RNA cleavage, it seems highly likely that RNA conformation is the primary determinant of the position(s) of RNA degradation.
Fe(II)-BLM-mediated DNA cleavage has long been known to proceed with high efficiency at a few sites that are a subset of those utilized under more forcing conditions (e.g., refs. 23 and 25). It may be that these sites reflect microheterogeneity of DNA structure that produces sites highly susceptible to cleavage by Fe(II)-BLM. Clearly, if tertiary interactions in RNA and DNA do constitute the source of highly selective cleavage, the structural characterization of such sites would permit the subsequent use of BLM as a tool for analysis of polynucleotide tertiary structure.
Chemistry of RNA Nucleotide Cleavage by Fe-BLM. The foregoing assignment of the position of BLM-mediated cleavage rests on the assumption that the chemistry of RNA strand scission by Fe(II)-BLM is mechanistically analogous to that of DNA; accordingly, this has been studied directly in several ways.
BLM-mediated DNA degradation is an oxidative process that requires oxygen and any one of several redox-active metals ions; it is greatly facilitated by reducing agents. The products of DNA degradation include free bases and base propenals (1, 2). We found that the degradation of tRNAHiS precursor also proceeded readily in the presence of Fe(II)*BLM but not in the presence of Fe(III)jBLM and was enhanced substantially by ascorbate. Although RNA degradation in a fashion analogous to that of DNA would not be expected to produce base propenals, due to differences in the sugar moieties of RNA and DNA, Magliozzo et al. (12) reported that adenine and uracil were produced from tRNA. To confirm that the tRNAHiS precursor was degraded oxidatively at uridine-35, we prepared a tRNAHiS precursor transcript containing [3H]uridines labeled within the pyrimidine moiety. Treatment with Fe(II)-BLM produced cleavage at the site believed to be uridine-35; free [3H]uracil, identified by HPLC analysis, was obtained in amounts consistent with the extent of degradation produced at position 35 (data not shown).
Products have been characterized after the degradation of DNA (26, 27) and of short DNA oligonucleotides having limited numbers of sites degraded efficiently by Fe-BLM (17) . The latter substrates have proven particularly useful because degradation can occur near the end of a DNA duplex, affording relatively small products amenable to precise chemical analysis. As shown in Fig. 5 , for example, d(CGCTAG CG) undergoes strand scission at cytidine-3, resulting in the formation of three products: (i) a dinucleotide (Structure 1) having a 3'-(phosphoro-2"-O-glycolate) terminus, (ii) cytosine propenal (Structure 2), and (iii) a pentanucleotide (Structure 3) containing a 5' phosphate. Also formed (data not shown) is a second set of products consisting of free cytosine and an alkali-labile lesion; these are believed to derive from an initially formed C-4' hydroxynucleotide intermediate (28, 29) .
Because none of the strong RNA cleavage sites characterized thus far is close to the end of an RNA substrate, none could be used for the type of product analysis illustrated above for DNA. Therefore, to determine whether Fe-BLM could degrade an RNA nucleotide oxidatively, we employed HOv + (Fig.  5, Structure 1) , unequivocally demonstrating the oxidative degradation of nucleotide-3 regardless of the orientation of the C-2' hydrogen. Also formed from each oligonucleotide was cytosine, consistent with the observation of free base formation from tRNA (12) .
Implications. Although BLM is generally thought to exert its antitumor effects by DNA damage, a few observations suggest that DNA may not constitute the only relevant locus. These include the extraordinary levels of BLM-mediated chromatin damage required to render cultured mammalian cells nonviable (5) and the lack of correlation between growth inhibition and DNA damage for individual BLM congeners (6) .
Given the exceptional selectivity for destruction of certain RNAs, even in the presence of much larger amounts of nonsubstrate RNAs, it seems possible that RNA is a therapeutic target for BLM. This thesis has the obvious virtues that (i) RNA is readily accessible within the cytoplasm, thus obviating the problem of delivery to the cell nucleus, (ii) while bound to proteins in many cases, cytoplasmic RNAs may nonetheless be more accessible than DNA, and (iii) the selectivity of RNA cleavage may well be sufficient to account for the observed therapeutic selectivity of BLM. In addition, although the cellular capacity for repair of double-strand DNA breaks is not clear, single-strand DNA damage can be repaired readily (5, 6, 30, 31) . In contrast, BLM-mediated damage to (m)RNA would be irreversible, possibly leading to an insufficiency of critical proteins whose turnover is fast relative to mRNA production (32) . The selective destruction of the mRNA for a protein required for progression of cells into mitosis (33, 34) could also account for the observed growth arrest of BLM-treated cells in late G2 phase (5, 6, 30, 31) . Alternatively, the inhibitory effects of BLM could be expressed by highly selective destruction of an RNA critical for cellular function (e.g., a rRNA or specific tRNA).
The foregoing thesis should be amenable to experimental inquiry, e.g., by monitoring the deletion of specific proteins after BLM treatment of cells. The present findings also suggest other possible uses for BLM, such as in the treatment of pathogens that utilize RNA as their template molecules.
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